Salute e Benessere

3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive…

"Rune's dedication, energy, and relentless pursuit of innovation have been invaluable in building 3Shape into the global market leader it is today," said Jacob Paulsen, CEO, 3Shape. "We are delighted that Rune will continue to contribute in his new capacity, working directly with me to guide our next chapter." "Rune's dedication, energy, and relentless pursuit of innovation have been invaluable in building 3Shape into the global market leader it is today," saidJacob…
PR Newswire
12/09/2025

Update on Information Relating to the General Meeting of September 30, 2025

Update on Information Relating to the General Meeting of September 30, 202561 Founding, Historical, Employee and Executive Shareholders of the Company, Representing Approximately 20.1% of Voting Rights have entered into a Shareholders’ Agreement NANTES, France – September 12, 2025, 8:00 a.m. – OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnemo: OSE) has been informed of the execution, on September 11, 2025, of a shareholders’ agreement (the “ Agreement ”) between 61 founding,...
Nasdaq GlobeNewswire
12/09/2025

United Imaging Intelligence: 31 Medical AI Applications Receive CE Marking

In addition to this year's certifications, earlier CE approvals already spanned key clinical domains including neurology, cardiology, thoracic care, oncology, and nuclear medicine. Together, these solutions cover the entire clinical workflow from early detection and diagnosis to medical research, while spanning a broad spectrum of imaging modalities. This breadth and depth highlight UII's ability to deliver real-world value across diverse clinical settings. In addition to this year's...
PR Newswire
12/09/2025

Dyslipidemia Market is Anticipated to Accelerate in the Coming 10 Years Due to…

Dyslipidemia Market Summary Dyslipidemia Market Summary Discover the dyslipidemia new treatment @New Treatments for Dyslipidemia Key Factors Driving the Growth of the Dyslipidemia Market Rising Prevalence of Cardiovascular Diseases The increasing incidence of heart disease and stroke worldwide is a primary driver for the demand for effective lipid-lowering treatments. DelveInsight analysts project that the prevalence of dyslipidemia is expected to grow during the...
PR Newswire
11/09/2025

Zealand Pharma increases its share capital as a result of the exercise of…

Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 11, 2025–Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has by decision of the Board of Directors increased its share capital by a nominal amount of DKK 20,924 divided into...
Nasdaq GlobeNewswire
11/09/2025

Annual Report 2024/25 - Growing revenue and EBITDA

ANNOUNCEMENT NO. 292 11 September 2025Annual Report 2024/25 (1 July 2024 - 30 June 2025) Growing revenue and EBITDA ChemoMetec’s revenue grew by 22% to DKK 495.6 million in 2024/25, and operating profit (EBITDA) increased by 39% to DKK 258.0 million. The positive revenue performance reflected an increase in sales of both instruments, consumables and services. The launch of the new XcytoMatic products is proceeding as planned. “Along with our strong focus on creating renewed...
Nasdaq GlobeNewswire
11/09/2025

Guidance for the 2025/26 financial year

ANNOUNCEMENT NO. 291 11 September 2025Guidance for the 2025/26 financial year ChemoMetec today approved the annual report for 2024/25, including the guidance for 2025/26, which is considered inside information.For 2025/26, ChemoMetec expects revenue in the range of DKK 545-565 million (2024/25: DKK 495.6 million) and EBITDA in the range of DKK 295-315 million (2024/25: DKK 258.0 million).The annual report for 2024/25, which is released along with this announcement, sets out...
Nasdaq GlobeNewswire
11/09/2025

Psoriatic Disease To Take Center Stage at the UN General Assembly: IFPA Calls…

Read more about this event and register: https://pages.devex.com/devex-at-unga-80 Read more about this event and register:https://pages.devex.com/devex-at-unga-80 Psoriatic disease is a lifelong, systemic inflammatory condition, often coexisting with other NCDs, such as diabetes, obesity, cardiovascular diseases and depression. An estimated 60 million people live with the disease. Despite the numbers, psoriatic disease has been overlooked in the health systems worldwide. The first...
PR Newswire
11/09/2025

Precision Medicine Market to Reach USD 103.73 Billion by 2035, with CAGR 11.3%…

Precision medicine leverages genomics, biomarkers, artificial intelligence (AI), and advanced diagnostics to tailor treatments to individual patients. Its rapid integration into clinical care is reducing trial-and-error prescribing, improving outcomes, and lowering unnecessary healthcare costs. Precision medicine leverages genomics, biomarkers, artificial intelligence (AI), and advanced diagnostics to tailor treatments to individual patients. Its rapid integration into clinical care is…
PR Newswire
11/09/2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of August 31, 2025(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Paris, France (September 11, 2025 - 6:00 pm)– As of August 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down...
Nasdaq GlobeNewswire
11/09/2025

Ipsen - August 2025 - Monthly information relative to the total number of voting…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)31 August 202583,814,526Gross...
Nasdaq GlobeNewswire
11/09/2025

OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment…

OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell CancerA total of 105 HLA-A2 positive patients enrolled in the Combi-TED study, which explores the combination of Tedopi® with either an anti-PD1 checkpoint inhibitor or chemotherapy as a second-line treatment for metastatic Non-Small Cell Lung Cancer following first-line...
Nasdaq GlobeNewswire
11/09/2025

Medical Sensors Market worth US$4.48 billion by 2030 with 7.9% CAGR |…

Browse in-depth TOC on "Medical Sensors Market" Browse in-depth TOC on "Medical Sensors Market" 581 - Tables 68 - Figures 453 - Pages By end users,the medical sensors market is segmented into hospitals & clinics; nursing homes, assisted living facilities, long-term care centers, and home care settings; and other end users. In 2024, the hospitals & clinics segment held a significant market share in the medical sensors market due to several key factors driving...
PR Newswire
11/09/2025

Foley Catheters Market worth US$1,205.0 million by 2030 with 5.3% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166415161 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166415161 Browse in-depth TOC on "Foley Catheters Market" 427 - Tables 55 - Figures 355 - Pages By coating type,the Foley catheters market is categorized into antimicrobial-coated Foley catheters, hydrophilic or lubrication-coated Foley catheters, and uncoated Foley catheters. In 2024, the...
PR Newswire
11/09/2025

Zentiva, a leading European generics pharmaceutical company, announces sale from…

GTCR is a leading private equity firm with a long history of investments in the healthcare sector and deep domain expertise in the pharmaceutical industry specifically, having invested behind several leading platforms and completed dozens of acquisitions in the space in the last 20 years. With GTCR's track record in the pharmaceutical space and its focus on partnering with management teams to build market-leading companies through organic growth, product innovation and strategic acquisitions, it…
PR Newswire
11/09/2025

Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs…

National Library of Medicine continued: "A combination of conventional and novel methods of digital and traditional biomarker detection with portable, autonomous, and miniaturized devices can revolutionize medical diagnostics in the coming years. This article focuses on a comparison of traditional clinical practices with modern diagnostic techniques based on AI and machine learning (ML). The presented technologies will bypass laboratories and start being commercialized, which should lead to…
PR Newswire
11/09/2025

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market…

Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a distribution agreement (the “Agreement”) with Scientific Pharmacy LLC (“Scientific Pharmacy”) for its Sky Premium Life food supplement products in Oman.Scientific Pharmacy, the retail and wholesale arm of Planet Pharmacies in Oman, is a leading healthcare and beauty company...
Nasdaq GlobeNewswire
11/09/2025

Philips and Masimo announce innovation partnership to advance access to patient…

Amsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, andMasimo(NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies are taking a bold new approach in accelerating the development and delivery of next-generation...
Nasdaq GlobeNewswire
11/09/2025

European Society of Cardiology (ESC) Congress 2025 Late Breaking Results Confirm…

Study results confirmed FAI-Score's predictive value for cardiac mortality: Study results confirmedFAI-Score 's predictive value for cardiac mortality: Caristo'sFAI-Scoretechnology was originally developed atOxford Universitywith funding from The British Heart Foundation ( BHF ). ProfessorCharalambos Antoniades, BHF Chair of Cardiovascular Medicine at theUniversity of Oxford and lead investigator of the study, commented: "Inflammation is a key process for coronary...
PR Newswire
11/09/2025

ANTARES VISION GROUP SIGNS STRATEGIC AGREEMENT WITH THE MEDICINES CONTROL AGENCY…

Antares Vision Group is proud to partner with a local Gambian organization, Africa Agenda Network (AAN) in this groundbreaking initiative. "Our role is to ensure that the local context, needs, and perspectives of all stakeholders are fully integrated into the implementation. This cooperation highlights the importance of strong local structures and inclusive engagement to achieve sustainable success for The Gambia and the broader ECOWAS (Economic Community of West Africa States)…
PR Newswire
11/09/2025

Trusted in 100+ Countries: YR Fitness Brings Independent Design to the Global…

Founder George Yang believes in building equipment that lasts and inspires:"We make products with heart. We make products with standard." FounderGeorge Yangbelieves in building equipment that lasts and inspires: "We make products with heart. We make products with standard." His vision has shaped 200+ patents and iconic series like the 73 Tough, 61A Racing, and C4 Revival, proving YR can stand alongside international leaders. YR Fitness is also recognized as one of the…
PR Newswire
11/09/2025

Inpharmus Becomes a Leader in Rare Diseases and Oncology in the MERAT

Founded in 2013 with the vision of providing healthcare solutions worldwide, Inpharmus continues to create value in rare diseases and oncology. With innovative products and services, it has positioned itself as a trusted partner, combining medical expertise with a global outlook. After achieving fivefold growth in Gulf countries and identifying strategic opportunities in the CIS region, Inpharmus recently opened a new office inMoscow, complementing its hubs inIstanbulandDubai...
PR Newswire
11/09/2025

Trusted in 100+ Countries: YR Fitness Brings Independent Design to the Global…

Founder George Yang believes in building equipment that lasts and inspires: "We make products with heart. We make products with standard." FounderGeorge Yangbelieves in building equipment that lasts and inspires: "We make products with heart. We make products with standard." His vision has shaped 200+ patents and iconic series like the 73 Tough, 61A Racing, and C4 Revival, proving YR can stand alongside international leaders. YR Fitness is also recognized as one of the…
PR Newswire
11/09/2025

Lundbeck showcases new clinical migraine data, including long-term preventive…

In the phase 4 RESOLUTION trial,7 the early, clinically meaningful improvements in migraine symptom and burden observed during the initial placebo-controlled period were sustained during the open-label extension period. Around 50% of patients achieved a ≥50% reduction from baseline in monthly migraine days (MMDs) and achieved approximately nine days fewer MMDs at the end of the 12 week OLE, compared to baseline at the start of the RESOLUTION trial (baseline was 20.9 MMDs).1 In the phase 4...
PR Newswire
11/09/2025
Altri  Comunicati